PNC Financial Services Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

PNC Financial Services Group’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,700	Closed	-$122K	–	4263
2018 Q3	$122K	Buy	3,700 +1,000	+37%	+$25.7K	﹤0.01%	2478
2018 Q2	$61K	Buy	2,700 +500	+23%	+$11.9K	﹤0.01%	2857
2018 Q1	$64K	Buy	2,200 +1,000	+83%	+$29.3K	﹤0.01%	2811
2017 Q4	$33K	Sell	1,200 -200	-14%	-$6.21K	﹤0.01%	3155
2017 Q3	$51K	Buy	+1,400	New	+$43.3K	﹤0.01%	2926
2015 Q1	–	Sell	-1,000	Closed	-$8K	–	4796
2014 Q4	$8K	Sell	1,000 -504	-34%	-$4.61K	﹤0.01%	3442
2014 Q3	$16K	Buy	+1,504	New	+$19.1K	﹤0.01%	3137

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PNC Financial Services Group's AVEO Position: Q4 2018 in Review

PNC Financial Services Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2018, closing a stake of 3,700 shares — an estimated $122K sold.

PNC Financial Services Group first reported a position in AVEO in Q3 2014 and held it in 7 quarters. The position peaked at $122K in Q3 2018. 99 funds tracked by Wall St. Rank hold AVEO as of Q4 2018.

PNC Financial Services Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
PNC Financial Services Group sold 3,700 AVEO Pharmaceuticals, Inc. shares in Q4 2018, an estimated $122K.
PNC Financial Services Group first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2014 and held it in 7 quarters.
PNC Financial Services Group's AVEO Pharmaceuticals, Inc. position peaked at $122K in Q3 2018.
99 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2018.

Based on PNC Financial Services Group's 13F filing for Q4 2018, filed 8 Feb 2019.